Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for WCIG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -0.0046M
March 31, 2026 -0.0011M
September 30, 2025 -0.0096M
June 30, 2025 -0.0091M
March 31, 2025 0.008M
September 30, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022 -0.0039M
September 30, 2022 0.0124M
June 30, 2022 -0.0024M
March 31, 2022 -0.0368M
December 31, 2021 0.0929M
September 30, 2021 -0.0331M
June 30, 2021 -0.0728M
March 31, 2021 -0.0171M
December 31, 2020
September 30, 2020 -0.007M
June 30, 2020 0.1742M
March 31, 2020 -0.181M
December 31, 2019 -0.0253M
September 30, 2019 -0.0194M
June 30, 2019 -0.0178M
Date Value
March 31, 2019 -0.0106M
December 31, 2018 -0.0065M
September 30, 2018 -0.0209M
June 30, 2018 -0.0349M
March 31, 2018 -0.0281M
December 31, 2017 -0.0241M
September 30, 2017 0.0049M
June 30, 2017 -0.002M
March 31, 2017 -0.0074M
December 31, 2016 -0.0297M
September 30, 2016 -0.0019M
June 30, 2016 -0.0165M
March 31, 2016 0.0013M
December 31, 2015 -0.0129M
September 30, 2015 -0.0116M
June 30, 2015 -0.0283M
March 31, 2015 -0.0295M
December 31, 2014 -0.0208M
September 30, 2014 -0.0546M
June 30, 2014 -0.068M
March 31, 2014 -0.0316M
December 31, 2013 -0.0261M
September 30, 2013 -0.0111M
June 30, 2013 -0.017M
March 31, 2013 -0.0204M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Arcis Resources Corp. --
Altria Group, Inc. 719.00M
Philip Morris International, Inc. 5.492B
Universal Corp. -117.12M
BioRegenx, Inc. 0.0266M